ArboretumHome PageNews Page Insider Q&A: Venturing in the Midwest with a VC founder Jan Garfinkle is not your typical VC founder, and not just because she’s a rare…Arboretum_JDOctober 7, 2019
Cardiac DimensionsHome PageNews Page Reduce FMR Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation and Slows Worsening of Heart Failure Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral…Arboretum_JDSeptember 12, 2019
Home PageMyHealthDirectNews Page Experian Acquires MyHealthDirect, Strengthening Leadership Position in Patient Access and Engagement Experian, the global information services company, announced today that it has signed a definitive agreement…Arboretum_JDAugust 8, 2019
ArboretumHome PageNews Page Arboretum Ventures Closes Fully Subscribed Fifth Fund at $250 million Arboretum Ventures, a leading healthcare venture capital firm, today announced the closing of its fifth…Arboretum_JDJune 14, 2019
ArboretumHome PageNews Page Ten VCs Join NVCA Board and Jan Garfinkle Appointed Chair at VCs-to-DC The National Venture Capital Association (NVCA) announced that Jan Garfinkle, Founder & Managing Partner at…Arboretum_JDJune 7, 2019
Home PageNews PageStrata Oncology Arcus Biosciences and Strata Oncology Announce Clinical Development Collaboration for Anti-PD-1 Antibody AB122 Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, and…Arboretum_JDMay 2, 2019
Cardiac DimensionsHome PageNews Page New Data Confirms Cardiac Dimensions’ Carillon® System Provides Acute Hemodynamic Efficacy in Patients with Functional Mitral Regurgitation Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments to address functional…Arboretum_JDApril 26, 2019
Fifth EyeHome PageNews Page Fifth Eye Inc. Raises $11.5M Series A Funding Round Led by Arboretum Ventures and Cultivation Capital Fifth Eye uses continuous physiologic waveforms to build clinical early warning systems that enable proactive…Arboretum_JDApril 1, 2019
Home PageNews PageSI-Bone SI-BONE, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of…Arboretum_JDMarch 7, 2019
Home PageNews PageNxThera New Four-Year Data Demonstrate Rezūm™ Water Vapor Therapy Offers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms Boston Scientific Corporation (NYSE: BSX) today announced that data from a randomized clinical trial demonstrate…Arboretum_JDJanuary 29, 2019